Avita Medical | Der Umsatz



Sales Veränderung Datum
Adcock Ingram Holdings ZAR 4.9B 162.28M 2024-06
Celltrion KRW 1.06T 181.72B 2024-12
Clinuvel Pharmaceuticals AUD 55.92M 23.66M 2024-06
Cochlear AUD 1.14B 38.6M 2024-06
CSL USD 6.75B 1.31B 2024-06
Cspc Pharmaceutical CNY 6.32B 78.77M 2024-12
Dianthus Therapeutics USD 1.33M 846K 2024-12
Ecofibre AUD 7.63M 1.27M 2024-06
Kangmei Pharma CNY 1.4B 126.12M 2024-09
Knight Therapeutics CAD 92.26M 3.31M 2024-09
Laboratorios Farma 434.41M 256.25M 2024-12
Malin Corporation EUR 19.2M 2.6M 2020-12
Mayne Pharma AUD 200.47M 12.57M 2024-06
Medical Developments International AUD 7.54M 0 2023-12
Nanosonics AUD 45.19M 34.45M 2024-06
Neuren Pharmaceuticals AUD 194.1M 163.93M 2024-12
Organigram Holdings CAD 42.73M 1.97M 2024-12
Pacific Edge NZD 10.96M 5.32M 2024-09
Paradigm Biopharmaceuticals AUD 5.25M 3.97M 2024-06
Pharma Mar EUR 48.36M 2.71M 2024-12
Polynovo AUD 59.52M 31.5M 2024-12
PYC Therapeutics AUD 6.58M 2.54M 2024-06
Qiagen NV USD 499.93M 32.58M 2024-12
Ramsay Health Care AUD 8.59B 12M 2024-12
ResMed USD 1.28B 57.58M 2024-12
Sartorius EUR 907M 113.4M 2024-12
Sino Biopharmaceutical CNY 15.87B 592.96M 2024-06
Telix Pharmaceuticals AUD 419.04M 55.08M 2024-12
Tilray USD 264.23M 53.28M 2025-03
Zhangzhou Pientzehuang Pharmaceutical 2.8B 320M 2024-09



Avita Medical Der Umsatz - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Apr 2025.